Disease evidence hub
A curated view of published Influenza research, auditable classifier relationships, and its publication timeline.
Evidence timeline
Monthly publication counts from the catalogue show how research activity changes over time.
24 publication months · peak 2026-08 (42)Guidance and policy markers identify dated publications in the curated catalogue; they do not by themselves establish that an official policy changed on that date.
Evidence stream
30 of 838 publications shown
Frontiers in Microbiology
Why it matters now With no confirmed circulating B/Yamagata-lineage viruses since March 2020, the authors frame B/Victoria protection as the current priority of influenza B vaccination, and the findings are presented as informing broadly protective influenza B vaccine development.
Nature Communications
Why it matters now The platform may be relevant to rapid antibody and biomolecule development for influenza-related targets, although the supplied abstract does not establish clinical effectiveness, epidemiological utility, or readiness for public-health implementation.
Journal of Clinical Medicine
Why it matters now The findings suggest that, among hospitalized adults tested for respiratory viruses, influenza was not associated with a higher short-term hazard of newly diagnosed atrial fibrillation, while atrial fibrillation identified during hospitalization was associated with increased one-year mortality.
Journal of Gerontology and Geriatrics
Why it matters now The article identifies influenza vaccination as an increasingly recognized component of cardiovascular disease prevention and secondary prevention frameworks in American and European guidelines.
Frontiers in Public Health
Why it matters now The low detected prevalence coupled with mostly symptom-free positives suggests potential silent circulation in academic settings, and point-of-care antigen screening appeared operationally practical there.
PLOS Medicine
Why it matters now The findings indicate that conventional stockpiles sized to cover 25% of a population may be insufficient by themselves during severe pandemics. The authors present capacity-based planning, potentially combining targeted reserves, temporary non-pharmaceutical measures, and flexible care delivery, as an preparedness option to evaluate.
Infectious Diseases of Poverty
Why it matters now The abstract frames HPAI as a major infectious disease threatening the poultry industry and public health, and describes the study as contributing to understanding HPAI transmission mechanisms across hosts and to providing a scientific basis for differentiated surveillance in the region.
Pediatrics & Neonatology
Why it matters now The findings suggest that vaccinating pregnant women against influenza provides indirect protection to infants too young for their own vaccination, particularly those at highest risk for severe complications.
Emerging infectious diseases
Why it matters now The approach is framed in the context of global health risks posed by highly pathogenic avian influenza A(H5Nx), clade 2.3.4.4b, and offers a tool to improve environmental influenza surveillance.
Infection, Genetics and Evolution
Why it matters now The authors suggest that ongoing airport wastewater monitoring may offer early alerts to health agencies and support coordinated response, pending cross-border cooperation.
Scientific Reports
Why it matters now The authors describe considerable vaccination gaps in sepsis survivors and identify general-practitioner counselling and vaccination-status checks as potential elements of sepsis aftercare.
Journal of Virology
Why it matters now The work indicates continued H5N1 circulation in cows may allow viral changes that evade Mx defenses, potentially raising spillover or pandemic risk.
Journal of Clinical Microbiology
Why it matters now Reliable subtyping of A(H3N2), including drifted and subclade K viruses, supports diagnostic preparedness and influenza surveillance capacity nationally and internationally.
Life
Why it matters now Linking spatial, temporal, and genetic monitoring may help locate high-risk areas and reinforce control of HPAI in Bulgaria.
BMC Infectious Diseases
Why it matters now Age- and season-specific peaks suggest value in tailoring surveillance by school-age and winter periods, per the authors' stated support for informed monitoring.
PLOS One
Why it matters now The authors argue these understudied species may sustain virus transmission in mixed systems, so including them in routine monitoring could aid early detection and spillover reduction.
PLOS One
Why it matters now The results suggest chlorous acid water could be useful in real-world low-temperature poultry settings, though the abstract stops at suggesting potential utility.
Epidemiology and infection
Why it matters now Improving vaccination coverage in under-vaccinated groups is highlighted as a continuing public health priority based on the mediation results.
Infection
Why it matters now The documented hospital load supports prioritising RSV prevention, such as vaccination, within older adult programmes alongside influenza control.
Journal of Information Systems and Informatics
Why it matters now More accurate influenza forecasting from surveillance data may support seasonal preparedness using nearly three decades of recorded detections.
Environmental Research: Health
Why it matters now Skilful climate-informed forecasts may aid early warning and preparedness, offering operationally relevant support for public health planning in Australia.
Journal of Virology
Why it matters now Findings clarify correlates of immune protection and may inform design of broadly protective influenza B vaccines and antibody therapies.
Journal of Virology
Why it matters now The authors state the results may aid prediction of cross-species transmission potential and host-targeted antiviral design, based on the identified molecular interface.
Journal of Virology
Why it matters now Conservation of the lateral patch among animal and human H1Nx viruses suggests it may be a useful target for preparedness against emergent pandemic strains.
Nature Communications
Why it matters now Optimizing genomic sequencing techniques for wastewater enhances the capacity to monitor Influenza A viruses within a One Health framework. These methodological improvements support the routine tracking of diverse and potentially emerging viral subtypes in environmental samples.
Frontiers in Immunology
Why it matters now The observed safety profile and substantial, albeit strain-variable, antibody production reinforce current immunization guidelines for people living with HIV. This data aids in shaping regional vaccination strategies for vulnerable populations.
Microorganisms
Why it matters now The emergence of this specific bacterial lineage in the region underscores the importance of ongoing genomic monitoring for invasive streptococcal infections. It also emphasizes the clinical necessity of evaluating for toxic shock syndrome in individuals presenting with shock subsequent to viral respiratory illnesses.
mBio
Why it matters now The results indicate hormonal environment influences vaccine-induced immunity beyond chronological age. This may inform understanding of variable influenza vaccine responses across sex and age groups.
Journal of Virology
Why it matters now The findings identify temperature-tolerant replication as a possible adaptive property of avian-origin PB1 genes. The abstract states that this could inform assessment of zoonotic adaptation and countermeasure development, but it does not establish human transmission risk or pandemic potential for a circulating strain.
Open Forum Infectious Diseases
Why it matters now The findings provide comparative immunogenicity evidence for mRNA-1010 as a seasonal influenza vaccine candidate in adults aged 50 years or older. The abstract reports antibody outcomes rather than direct clinical effectiveness, disease, hospitalization, or mortality outcomes.
